Epidemiology of Pneumocystis jirovecii Pneumonia and (Non-)use of Prophylaxis

Objectives: Pneumocystis jirovecii pneumonia (PCP) is an AIDS-defining illness. In patients with HIV, the benefit of PCP prophylaxis is well-defined when the CD4 T-cell count decreases below 200 cells/μL. In other immunocompromised patients, the value of PCP prophylaxis is not always as well-establi...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Front Cell Infect Microbiol
Main Authors: Dunbar, Albert, Schauwvlieghe, Alexander, Algoe, Sheruna, van Hellemond, Jaap J., Reynders, Marijke, Vandecasteele, Stefaan, Boelens, Jerina, Depuydt, Pieter, Rijnders, Bart
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2020
Teme:
Cellular and Infection Microbiology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7243458/
https://ncbi.nlm.nih.gov/pubmed/32500040
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcimb.2020.00224
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki